Ligand validation:5VEW

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5VEW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VEW_OLC_B_1204	21%	49%	0.18	0.833	1.1	0.88	1	1	0	0	76%	0.76
5VEW_OLC_A_1202	18%	49%	0.226	0.81	1.02	0.94	1	2	1	0	100%	1
5VEW_OLC_A_1203	13%	47%	0.163	0.745	1.15	0.93	1	1	0	0	76%	0.76
5VEW_OLC_B_1201	7%	51%	0.294	0.749	0.99	0.91	1	2	0	0	100%	1
5VEW_OLC_B_1205	4%	40%	0.197	0.645	1.27	1.12	1	2	0	0	60%	0.6
5VEW_OLC_B_1203	3%	53%	0.306	0.654	1	0.82	1	1	2	0	100%	1
6KJV_OLC_B_2002	9%	59%	0.276	0.761	0.83	0.71	2	1	2	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.